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INTRODUCTION 
As a naturally occurring biopolymer, alginate has been 
used successfully in the pharmaceutical industry as a 
gelling agent and colloidal stabilizer, and holds strong 
potential in the area of drug delivery. Extracted from 
brown algae, alginate polymers consist of linear, 
unbranched polysaccharides with acid residues of 1, 4’-
linked-β-D-mannuronic acid and α-L-gluronic acid 
residues. The residues are arranged in blocks along the 
chain and vary in sequence and composition. There are 
numerous physical characteristics possessed by alginate 
that enable it to form matrices to encapsulate and deliver 
various proteins and cells in vivo. Specifically, alginate 
matrices contain aqueous internal environments ideal for 
the encapsulation of proteins and small molecules. These 
encapsulations form at room temperature, independent of 
organic solvents, and they have a high rate of 
macromolecular diffusion due to their porous gel state that 
may be controlled through specific coating procedures. In 
addition, alginate matrices are very biodegradable and can 
be broken down under normal physiological conditions 1 . 
The preparation of alginate beads containing an assortment 
of substances can be achieved through various means. 
These approaches cover large bead preparation, microbead 
preparation, matrix block preparation, and in situ gelling 
systems. In general, alginate beads are formed when a 
solution of sodium alginate and the desired substance is 
extruded as droplets into a divalent solution to encourage 
cross-linking of the polymers. Such cross-linking solutions 
may include cations such as Ca2+, Sr2+ or Ba2+, while 
monovalent cations and Mg2+ do not induce gelation, and 
Ba2+ and Sr2+ ions produce very strong alginate gels (Clark 
and Ross-Murphy., 1987). Numerous other cations 
including Pb2+, Cu2+, Cd2+, Co2+, Ni2+, Zn2+, and Mn2+ will 
induce gelation, but due to their toxicity they are rarely 
used. In the gelation process, the polymer chains are cross-
linked by the exchange of sodium ions from gluronic acids 
with divalent cations, forming what is referred to as the 
“egg-box” 2 as represented in Figure 1. 
In the present investigation, an extended and controlled 
release composition and formulation of Ciprofloxacin, 
which is a synthetic antimicrobial having a quinolone 
structure and broad spectrum antibiotic capable of 
providing detectable blood levels over 10 hr was 
formulated using expandable, gelling, swellable 
hydrocolloid polymer along with the variety of oils which 
acts as a barrier in retardation of drug from these beads 
matrixes using calcium chloride as a cross linking agent. 
Although many drugs have been extensively investigated 
using natural polymeric carrier , the studies on the release 
of antibiotic drugs are limited.  . 
The use of oil entrapped calcium pectinate beads has been 
used in various ways for sustained release of drugs or for 
the targeting drugs to colon3. Theophylline tablets 
composed of mineral oil entrapped agar for the controlled 
release4 have been reported. Sodium alginate emulsion 
beads for extended release formulations have not been 
tested. The effects of factor like type of oil, percentage of 
oil on the prepared beads were investigated. 
ABSTRACT 
The objective of this present work is to develop gastroretentive multiunit emulsion beads based on the oil for the sustaining 
effect of the Ciprofloxacin (CPX). By the technique which is based on emulsion gelation technique different oil was taken and 
incorporated in the mixture of CPX and sodium alginate (SA) as a hydrophilic polymer and this is extruded with the help of 
syringe in 4 % calcium chloride cross linking solution having curing time of 10 min. Prepared emulsion beads show a better 
portfolio in terms of drug release. The conventional emulsion beads (F4) shows a burst effect due to no incorporation of oil in 
it. Use of oil in the formulation acts as a barrier with SA and prolongs the effect of drug in the upper GI tract for a longer period 
of time and may be used in the treatment of upper GI tract infection. Other formulations in which oil used (F1, F2. F3) proves a 
better sustaining effect as compared to formulation (F4) and it was found that sodium alginate not only effective for the 
sustaining effect of drug alone. With use of oil and sodium alginates it proves a better polymer for this drug.  Data obtained 
from our present investigation we find out that retardation of the drug from the matrixes of drug in following order mentha oil > 
light liquid paraffin > castor oil and also explains the better encapsulation efficiency, % buoyancy and release profile. 
Key words: Ciprofloxacin, Sodium alginate, emulsion gelation technique, curing time, % buoyancy 
 
Soni et al                                Journal of Drug Delivery & Therapeutics; 2012, 2(5), 50-54    51 
© 2011, JDDT. All Rights Reserved                                                        ISSN: 2250-1177                                                     CODEN (USA): JDDTAO 
 
Figure 1: Egg box association of poly L- guluronate sequences of alginate and conversion of random coils to ribbon 
structures when cross linked with ca
2+
 ions. 
MATERIALS AND METHODS  
Materials  
Ciprofloxacin (CPX) was gifted by Axa parenteral, India. 
Sodium alginate was purchased from Sigma-Aldrich (St. 
Louis, USA). Water used in the formulations was of HPLC 
grade (Merck) and all other chemicals used were of 
analytical grade. 
Methods 
Floating beads were prepared by (Table 1) by extruding an 
SA containing different grades of oil with drug with the 
help of 25 ml hypodermic syringe, into CaCl2 solution 
(4%w/v ) at room temperature (280C). The beads formed 
instantaneously, were cured for 10 minutes in gelation 
medium at 37 0C with mild agitation. Prepared beads were 
separated by filtration, washed thrice with deionized water 
and dried in an oven at 35 0C for 12 hours than kept in a 
desiccator for another 12 hours before further experiments. 
Table 1: Formulation composition of alginate beads 
Formulation    CPX       S.A          Mentha oil        Light liquid paraffin     Castor oil       Calcium   Curing 
code             (mg)     (%w/v)            (ml)                            (ml)                          (ml)         chloride    time 
F1                     100         1.5                1.5                                                                                      4%        10 min. 
F2                     100         1.5                                                1.5                                                       4%       10 min. 
F3                     100         1.5                                                                                       1.5                4%      10 min. 
F4                     100         1.5                                                                                                             4%      10 min. 
Total volume of formulation was 10 ml 
RESULTS 
Particle size characterization 
Particle size was made by using optical microscope by 
calibrating it with eye piece and stage piece micrometer 
(Model BH-2, Olympus, Japan). The readings were made 
in triplicate and standard deviation was calculated. The 
particle size varies from 1.06 ±0.14 to 1.24 ± 0.13 mm. 
The main reason for this fluctuation in the particle size 
range is due to the nature of oil used.  
F3 formulation is having the largest particle size due to the 
nature of oil used and its concentration. Castor oil used 
shows some tackiness in its character and it has more 
density and volatility when compared with the other 
formulations oil used. This density and volatility also plays 
an important role in the size and sphericity of the 
formulation [5]. An incorporation of increase in 
concentration and volume of oil leads to the increase in 
size as well as change in sphericity of the emulsion beads. 
Volatility of the oil used also plays a vital role in the 
formulation. As the density of oil decreased the volatility 
increased. When these beads are dried the higher volatile 
oil evaporated quickly leading to the uneven 
morphological characteristics. Formulation (F4) having the 
smallest size due to the composition only of CPX and SA. 
It has the particle size of 1.06 ± 0.14. 
 
Figure 2: Histogram representing particle size (mm) 
Formulation (F1) having the particle size of 1.12 ± 0.09 
due to of volatility nature of menthe oil used because when 
these beads are dried the volatile oil component evaporated 
quickly leading to the uneven morphological profile and 
also alters the decreased in the particle size. 
Formulation (F2) shows the particle size of 1.16 ± 0.10 
also attributes the same phenomenon of nature of light 
liquid paraffin which has somewhat increase in viscosity 
which alters the morphology and size of the beads as 
compared to formulation (F3). 
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Drug entrapment efficiency 
The drug entrapment efficiency of each formulation was 
determined by extracting the crushed beads with 0.1M HCl 
(pH 1.2) for 180 min at 37 0C and then centrifuged at 5000 
rpm (Remi centrifuge). The supernatant layer was taken 
and suitably diluted with 0.1M HCl (pH 1.2) buffer, 
quantifying the amount of drug UV spectrophotometrically 
at 277 nm. The entrapment efficiency (EE) was calculated 
according to relationship: 
 
Formulation F1, F2, F3, F4 having the % entrapment 
efficiency of 77.12 ± 0.12, 82.09 ± 0.21, 84.34 ± 0.31, 
71.13 ± 0.26 respectively. Curing time is the most 
important factor for such types of results. Most of the drug 
diffuses out from the SA matrixes to the surrounding 
aqueous medium resulting in this entrapment efficiency. 
To overcome from this the curing time may be increased 
which may overcome this problem. The second and very 
most important consideration for this problem is the 
leakage of oil from the formulation. F1 formulation shows 
the % entrapment efficiency of 77.12 ± 0.12 which is only 
due to the leakage of oil from the   as seen during the 
preparation phase and not act as a barrier for release of the 
drug CPX. 
 
Figure 3: Histogram representing% entrapment 
efficiency 
Assessment of in vitro buoyancy of the floating beads 
The buoyancy of the gel beads was not dependent upon the 
hydrophilic polymer i.e sodium alginate concentration. 
Beads prepared with gas-generating agent remained 
buoyant on 0.1 M HCl for sufficiently long duration of 
time. Floating beads remained buoyant for upto 12 hours 
on 0.1 M HCl with no floating lag time. Upon contact with 
an acidic medium, the CaCO3 effervesced, releasing CO2. 
The released CO2 was entrapped in the gel network of 
sodium alginate producing buoyant formulation and thus, 
prolonged floating of beads. 
However data obtained for % buoyancy as depicted in 
table reveals that the due to the incorporation of the oil in 
the formulation leads to increase in buoyancy factor as 
clearly seen in the F1 and F2 formulation, in F3 
formulation the buoyancy factor somewhat decrease due to 
the nature of oil which has somewhat related to the density 
factor and the conventional F4 formulation leads to the 89 
% of buoyancy factor.  
 
Figure 4: Histogram representing% buoyancy 
Determination of density 
In human stomach fluid is having a density of 1.004 g/cm3. 
The object remains afloat in the stomach whose specific 
density is less than 1.004 g/cm3. So the density of the 
beads system is determined by using formula Density (d) 
was determined using the relationship d = m/v where v = 
πr2h. Density  ranges from 0.94-0.98 g/cm3.
 
Table 2: Representing particle size, % entrapment efficiency, % buoyancy, lag time and density of the formulations 
Formulation       Particle size ±              % E.E ±                            %                       Lag             Density 
Code                    S.D (mm)                    S.D (mm)                      buoyancy           time              (g/cm
3
) 
F1                    1.12 ± 0.08              77.12 ± 0.12              93              3 min            0.94 
F2                    1.16 ± 0.10              82.09 ± 0.21               90              5 min           0.93 
F3                     1.24 ± 0.13             84.34 ± 0.31               74             90 min          0.94 
F4                     1.06 ± 0.14             71.13 ± 0.26                89            15 min          0.98 
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In vitro release profile 
 
Figure 5: Release profile of formulations in 0.1 M HCl 
(pH 1.2) 
In vitro release profile was performed in dissolution 
apparatus type II (paddle type, Electrolab, Mumbai, India) 
in 0.1 M HCl (pH 1.2) at 50 rpm. 
Carried dissolution study however indicates that the there 
is rapid release of the drug in the initial phase however 
after that there is steady drug release takes place for a 
prolonged period of time. This is due to the drug is 
dragged to the outer surface of the beads during 
preparation process that gives the burst effect. Formulation 
F4 shows the burst effect because it has only the 
composition of drug and polymer and this single layer of 
polymer is not effective in barrier of drug release as shown 
in the above formulations. Formulation F1, F2, F3 have oil 
composition and this act as a barrier for drug release along 
with Sodium alginate and sustained the release of a drug 
from 8 hours to 10 hours.   
The release profile reveals that the sustaining effect was 
more effective in Formulation F1, F2, F3 in order of 
mentha oil > light liquid paraffin > castor oil whereas 
formulation F4 which is conventional formulation shows 
the burst effect release. 
Release kinetics of formulation  
In order to describe the kinetics of drug release from 
formulations, various equations were used, such as the 
zero-order rate equation, which describes the systems 
where the release rate is independent of the concentration 
of the dissolved species 6. The first-order equation 
describes the release from systems where dissolution rate 
is dependent on the concentration of the dissolving species. 
In vitro data were also fitted to Higuchi’s square root 
model 7, which describes the release from systems where 
the solid drug is dispersed in an insoluble matrix, and the 
rate of drug release is related to the rate of drug diffusion. 
Under some experimental situations the release mechanism 
deviates from the Fick’s equation, following an anomalous 
behaviour (non-Fickian release). In these cases a more 
generic equation can be used. Korsmeyer et al. developed 
a simple, semi-empirical model, relating exponentially the 
drug release to the elapsed time (Eq. [1]). 
Mt / M∞= K t n      [1] 
where Mt / M∞ is the fraction of drug released at time t ; K 
is a constant comprising the structural and geometric 
characteristics of beads; and n, the release exponent, is a 
parameter that depends on the release 
In case of CPX loaded oil emulsion beads, formulation F1, 
F3 and F2 followed zero order kinetics as evidenced by r2 
values, which were higher when fitted to zero order 
kinetics which explains that the drug release rate is 
independent of its concentration. Whereas, formulation F4, 
followed Higuchi kinetics, as evidenced by r2 values. The 
n values from drug release experiment ranged from 0.44-
0.48, with formulations F1 and F4 followed Quasi-Fickian 
diffusion and formulations F2, F3 followed anomalous 
non-Fickian diffusion. 
Table 3: Release kinetics of CPX from oil fabricated beads 
 
DISCUSSION AND CONCLUSION 
The main objective of present investigation was to prepare 
sodium alginate-oil based   complex beads in one step with 
the use of crosslinking agent and to explore the potential of 
the prepared beads in the oral delivery of water soluble 
drug. The different grades of oil used define the status of 
generally regarded as safe status (GRAS). Use of oil 
during our present investigation acts as a barrier and 
sustained the drug for a prolonged period of time. Our 
present investigation result shows that it is possible to 
develop a system which is based on oil by emulsion 
gelation technique and proves a better in terms of 
sustaining effect of the drug. The prepared beads examined 
for encapsulation efficiency, buoyancy behaviour and drug 
release profile study. These beads show better results in 
terms of release profile and extend the release of a drug for 
10-12 hours. These systems however may be beneficial in 
the treatment of stomach specific infections; however it 
needs more study. 
 
Formulation Code r
2 
Value  
n value 
Zero order First order Higuchi  
 
Korsmeyer-
Peppa’s  
F1 0.9739 0.5321 0.9709 0.9829 0.44 
F2 0.9641 0.5289 0.9894 0.9906 0.52 
F3 0.9846 0.5735 0.9741 0.9914 0.55 
F4 0.9525 0.5195 0.9926 0.9976 0.48 
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